BARCLAYS PLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 1 filers reported holding IMMUNITYBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$75
-55.4%
44,373
-26.6%
0.00%
Q2 2023$168
+124.0%
60,469
+46.5%
0.00%
Q1 2023$75
-94.2%
41,288
-83.9%
0.00%
-100.0%
Q4 2022$1,300
-99.9%
256,365
+1.3%
0.00%0.0%
Q3 2022$1,257,000
+3042.5%
253,030
+2229.3%
0.00%
Q2 2022$40,000
-39.4%
10,863
-6.7%
0.00%
Q1 2022$66,00011,6410.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders